The sharp divergence between passive index fund accumulation and active healthcare specialist exits suggests the stock may be in a 'passive support vs. active thesis breakdown' tug-of-war. Monitor upcoming earnings and pipeline catalysts for resolution — if the active sellers' thesis (likely pipeline risk or valuation) proves correct, passive buying alone may not sustain the stock.
Executive Summary
Institutional activity in Contineum Therapeutics (CTNM) during Q2 2026 was highly mixed: 17 buyers accumulated $51.4M in net new positions, while 10 sellers reduced holdings by $47.1M. The buying was dominated by mega-passive index funds (BlackRock, Fidelity, Geode, Northern Trust) doubling or adding positions, while the selling was concentrated among active healthcare-focused asset managers (Baker Bros., Ra Capital) fully exiting large stakes. The net effect is a modest $4.3M inflow, but the divergence between passive accumulation and active specialist exits creates an ambiguous signal.
Key Financial Metrics
Institutional Positions
Net institutional flow: $4.3M
▲ Buyers (17)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| BlackRock | DOUBLED | +208.5% | $33.8M | $25.1M |
| Fidelity | ADD | +27.6% | $17.0M | $6.4M |
| Geode | DOUBLED | +145.8% | $11.4M | $7.7M |
| Northern Trust | DOUBLED | +321.4% | $4.6M | $3.7M |
| Goldman Sachs | ADD | +61.9% | $8.2M | $4.1M |
▼ Sellers (10)
| Institution | Action | Change | Prev Value | Value Δ |
|---|---|---|---|---|
| Baker Bros. Advisors | EXIT | -100% | $18.6M | -$18.6M |
| Ra Capital Management | EXIT | -100% | $16.9M | -$16.9M |
| Millennium | TRIM | -39.3% | $20.1M | -$4.8M |
| Susquehanna International Group | NEAR_EXIT | -79.7% | $4.9M | -$3.6M |
| Marshall Wace | TRIM | -47.8% | $3.0M | -$1.0M |
Key Facts
- 17 institutional buyers added $51.4M in net new positions; 10 sellers reduced by $47.1M
- BlackRock doubled its stake (+208.5%) to $33.8M, the largest buyer
- Baker Bros. Advisors and Ra Capital Management each fully exited positions worth $18.6M and $16.9M respectively
- Mega-passive funds (BlackRock, Fidelity, Geode, Northern Trust, Goldman Sachs) were the dominant buyers
- Active healthcare specialists (Baker Bros., Ra Capital) and quant funds (Millennium, Point72, Susquehanna) were the primary sellers
- Net aggregate institutional inflow was approximately $4.3M
Financial Impact
17 buyers accumulated $51.4M in new positions while 10 sellers reduced holdings by $47.1M, resulting in a net institutional inflow of approximately $4.3M
Risk Factors
- Two large healthcare-focused holders (Baker Bros., Ra Capital) fully exited, signaling potential fundamental concerns
- 13F data is 45+ days stale; positions may have changed since quarter-end
- Passive buying may reflect index rebalancing rather than conviction in the company's prospects
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-CTNM-2026-Q2 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 4d ago | SC 13G | $8.31 | awaiting T+20 | — | — |
Sep 22, 2026 4w ago | Institutional Cluster | $13.40 $8.46 | ▼ −36.87% | ▼ −36.31% | — |
Jul 8, 2026 15w ago | Insider Cluster | $15.45 $15.35 | ▼ −0.65% | ▼ −2.89% | — |
Jul 2, 2026 16w ago | Insider Cluster | $15.53 $15.93 | ▲ +2.58% | ▲ +1.73% | — |
Jul 1, 2026 16w ago | Insider Cluster | $15.10 $15.75 | ▲ +4.30% | ▲ +4.72% | — |
Mar 5, 2026 33w ago | 8-K | $13.88 $13.44 | ▼ −3.17% | ▼ −1.13% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers